Amber Bio
PrivateLast Round
Seed
Aug 3, 2023
Total Funding Raised
$26M
Company Overview
Amber Bio is a biotechnology company that provides genetic medicine solutions through a proprietary RNA-writing gene-editing platform designed to address diverse genetic mutations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amber Bio Comparables
Compare Amber Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shape Therapeutics | 87% | |
| Ascidian Therapeutics | 85% | |
| EDIRNA, Inc. | 84% | |
Amber Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 3, 2023 |
Amber Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed |
| Playground Global | Seed |
| Pillar VC | Seed |
| Playground Global | Seed |
| Hummingbird Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2023
$26M round led by Andreessen Horowitz and Playground Global.
Amber Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amber Bio's valuation, stock price, and market status.